dipropylacetamide has been researched along with trans-2-en-valproate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenstrum, T; Capretta, A; Kim, AJ; Ohnmacht, SA; Panna, E; Werstuck, GH | 1 |
| Badir, K; Bialer, M; Hadad, S; Haj-Yehia, A | 1 |
1 review(s) available for dipropylacetamide and trans-2-en-valproate
| Article | Year |
|---|---|
Can we develop improved derivatives of valproic acid?
Topics: Animals; Anticonvulsants; Biotransformation; Drug Evaluation, Preclinical; Epilepsy; Fatty Acids, Monounsaturated; Prodrugs; Random Allocation; Stereoisomerism; Structure-Activity Relationship; Valproic Acid | 1994 |
1 other study(ies) available for dipropylacetamide and trans-2-en-valproate
| Article | Year |
|---|---|
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.
Topics: Anticonvulsants; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Molecular Structure; Valproic Acid | 2004 |